Get started
RocketTickers

AzurRx BioPharma Announces Positive Results from Phase 2 Trial w

Long
RocketTickers  
NASDAQ:AZRX   None
Beyond Technical Analysis
6
0
beyondta
AZRX: AzurRx BioPharma, Inc.
2019-09-25 07:30:00
AzurRx BioPharma Announces Positive Results from Phase 2 Trial with MS1819 in Cystic Fibrosis Patients
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.